- CA$121.89m
- CA$118.39m
- CA$109.85m
Brief: Imaflex Q3 EPS CAD 0.01
Brief: Imaflex Q1 EPS CAD 0.01
Brief: Imaflex Reports Q4 And FY 2024 Results Provides Business Update
Brief: Imaflex Resumes Normal Operations Following Cybersecurity Incident
Brief: Imaflex Announces Cyber Security Incident, Launches Investigation
Brief: Imaflex Announces Resignation Of Director Roberto Longo And Appointment Of Mario Settino
Brief: Imaflex Inc Stephan Yazedjian Officially Joins As President & CEO
Brief: Imaflex Appoints Stephan Yazedjian As President And CEO
Brief: USPTO Grants Patent To Imaflex For ADVASEAL
Brief: Imaflex Q3 revenue CAD 22.858 million
Brief: Imaflex Announces Q2 2023 Results And Provides Business Update
Brief: Imaflex Announces Change In Executive Leadership
Brief: Imaflex Announces Appointment Of President And Chief Executive Officer
Brief: Imaflex Announces Q1 2023 Results, Provides Business Update
Brief: Imaflex Announces Departure Of CFO
Brief: Imaflex Inc Q4 Revenue Falls 15.3%
Brief: Imaflex Announces Q3 2022 Results And Provides Business Update
Brief: Imaflex Submits Advaseal Registration Package To The EPA
Brief: Imaflex Inc Announces Q2 2022 Results And Provides Business Update